Navigation Links
HOYA ConBio Announces Educational Agreement With LVI Global
Date:2/20/2008

HOYA ConBio Lasers Featured At Premier Las Vegas Training Facility

FREMONT, Calif., Feb. 20 /PRNewswire/ -- HOYA ConBio(TM), a global leader in dental and aesthetic lasers, today announced an agreement with The Las Vegas Institute for Advanced Dental Studies (LVI), an internationally recognized leader in post-graduate dental education, in which VersaWave(TM) and DioDent(TM) Micro 980 lasers will be utilized at LVI's state-of-the-art teaching facility through 2009. The educational alliance is the latest development in HOYA ConBio's corporate outreach to partner with pioneers in dental continuing education.

"In the past, we've selected LVI as the host site for our HOYA ConBio College for laser dentistry training," said Timothy S. Gehlmann, President & CEO, HOYA ConBio. "This agreement takes our relationship to a new level and we are excited to move forward with comprehensive laser course offerings, providing a complete portfolio of products to achieve superior clinical results."

HOYA ConBio's VersaWave and DioDent Micro 980 dental lasers will be placed at LVI's 62,000 square-foot facility, which features two 10-operatory teaching clinics, a 60 bench hands-on workshop and six lecture halls. According to William G. Dickerson, DDS, LVI Global's founder and CEO, practicing dentists worldwide visit LVI to advance their education, knowledge and expertise in aesthetic, neuromuscular, occlusal, restorative and reconstruction dentistry.

"We share HOYA ConBio's belief that training is paramount to successful dentistry and we are pleased to feature their dental lasers at our first-class facility," commented Dennis Bonilla, LVI Global President. "Since 1995, LVI has set standards for clinical education in dentistry and our graduates are among the finest, most progressive dentists in the world. HOYA ConBio's dental lasers will be an integral part of our curriculum, available to the more than 6,000 LVI clinical alumni who attend our courses to le
'/>"/>

SOURCE HOYA ConBio
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. CleanRest(R) Announces a Groundbreaking Invention, The Worlds Cleanest Pillow(TM)
2. Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments
3. Thermage Announces Fourth Quarter and Full Year 2007 Financial Results
4. XTENT Announces 2007 Financial Results
5. VA Secretary Announces New Walla Walla Facility
6. TrailBlazer Announces Final Medicare Administrative Contractor Schedule for Claims Processing in Four States
7. Pennsylvania Department of Public Welfare Announces Grant Opportunity for Regional Autism Centers
8. Paine & Partners, LLC Announces Sale of Byram Healthcare to OPG Groep N.V.
9. MedCath Announces Venture With Two New Jersey Hospitals
10. Nu Skin Enterprises Announces Increase in Quarterly Dividend
11. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2Health News:Help Young Cancer Patients Enjoy Christmas This Season 2Health News:The NHS to Improve Patient Care by Better Engaging Staff 2
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5The Worlds Only Online Marketplace Dedicated to Buying and Selling Gently Used and New Special Needs Equipment 3A DifferentNeedz com 5284 1The Worlds Only Online Marketplace Dedicated to Buying and Selling Gently Used and New Special Needs Equipment 3A DifferentNeedz com 5284 2Marc J Fagel of the U S Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech Pharma Finance and Accounting Forum in San Fra 5282 1Marc J Fagel of the U S Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech Pharma Finance and Accounting Forum in San Fra 5282 2Mike Fuljenz and Universal Coin 26amp 3B Bullion Sponsors the NRA Eddie Eagle GunSafe Program 14381 1Mike Fuljenz and Universal Coin 26amp 3B Bullion Sponsors the NRA Eddie Eagle GunSafe Program 14381 2